All Stories

  1. Dynamic lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction

    Article • European Respiratory Journal, September 2021, European Respiratory Society (ERS)

    Prof DEMOSTHENES BOUROS

  2. Existing and emerging treatments for idiopathic pulmonary fibrosis

    Article • Expert Review of Respiratory Medicine, January 2019, Taylor & Francis

    Prof DEMOSTHENES BOUROS

  3. Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

    Article • Frontiers in Medicine, November 2017, Frontiers

    Prof DEMOSTHENES BOUROS

  4. Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study

    Article • Pulmonary Pharmacology & Therapeutics, October 2017, Elsevier

    Prof DEMOSTHENES BOUROS

  5. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts

    Article • Pulmonary Pharmacology & Therapeutics, October 2017, Elsevier

    Prof DEMOSTHENES BOUROS

  6. Incidence of cancer in patients with IPF.A retrospective multicenter study

    Article • September 2017, European Respiratory Society (ERS)

    Prof DEMOSTHENES BOUROS

  7. Impact of depression on patients with Idiopathic Pulmonary Fibrosis

    Article • September 2017, European Respiratory Society (ERS)

    Prof DEMOSTHENES BOUROS

  8. Efficacy and safety of pirfenidone in patients with IPF. A single center real-life experience

    Article • September 2017, European Respiratory Society (ERS)

    Prof DEMOSTHENES BOUROS

  9. Lung cancer in patients with idiopathic pulmonary fibrosis

    Article • Pulmonary Pharmacology & Therapeutics, August 2017, Elsevier

    Prof DEMOSTHENES BOUROS

  10. Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the ‘bed’ that counts and not ‘the sleepers’

    Article • Expert Review of Respiratory Medicine, March 2017, Taylor & Francis

    Prof DEMOSTHENES BOUROS, Ioannis Tomos

  11. Guidelines for Idiopathic Pulmonary Fibrosis: Everything Flows

    Article • Respiration, January 2017, Karger Publishers

    Prof DEMOSTHENES BOUROS

  12. Pirfenidone in Idiopathic Pulmonary Fibrosis “RECAP-itulating Safety into the Real World”

    Article • Respiration, January 2017, Karger Publishers

    Prof DEMOSTHENES BOUROS

  13. Chronic Kidney Disease and Idiopathic Pulmonary Fibrosis: Thinking Outside the Box in Disease Management and Prognostication

    Article • Respiration, January 2017, Karger Publishers

    Prof DEMOSTHENES BOUROS

  14. Metsovo Lung: A Story of Episteme, Techne, and Phronesis

    Article • Respiration, January 2017, Karger Publishers

    Prof DEMOSTHENES BOUROS

  15. Clinical experience with nintedanib for the treatment of IPF in 80 cases

    Article • September 2016, European Respiratory Society (ERS)

    Prof DEMOSTHENES BOUROS

  16. Association Study for 26 Candidate Loci in Idiopathic Pulmonary Fibrosis Patients from Four European Populations

    Article • Frontiers in Immunology, July 2016, Frontiers

    Professor Gernot Zissel, Prof DEMOSTHENES BOUROS

  17. Combined Pulmonary Fibrosis and Emphysema, a clinical review

    Article • COPD Research and Practice, February 2016, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  18. Cardiopulmonary Exercise Testing in Systemic Sclerosis: ‘Ars longa, vita brevis'

    Article • Respiration, February 2016, Karger Publishers

    Prof DEMOSTHENES BOUROS

  19. The Six-Minute Stepper Test: Solvitur ambulando

    Article • Respiration, January 2016, Karger Publishers

    Prof DEMOSTHENES BOUROS

  20. Critical Steps: A Non-Interventional, Multicenter, Prospective, Observational Study on Critical Handling Errors with DPI Use, in Asthma and COPD Patients

    Article • Journal of Pulmonary & Respiratory Medicine, January 2016, OMICS Publishing Group

    Prof DEMOSTHENES BOUROS

  21. Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE)

    Article • September 2015, European Respiratory Society (ERS)

    Prof DEMOSTHENES BOUROS

  22. Lung Involvement in Rheumatic Disease: Introduction

    Article • Respiration, January 2015, Karger Publishers

    Prof DEMOSTHENES BOUROS

  23. Idiopathic pulmonary fibrosis: on the move

    Article • The Lancet Respiratory Medicine, January 2014, Elsevier

    Prof DEMOSTHENES BOUROS

  24. Anti-acid treatment for idiopathic pulmonary fibrosis

    Article • The Lancet Respiratory Medicine, July 2013, Elsevier

    Professor Chris Bullen, Prof DEMOSTHENES BOUROS

  25. Management of Pleural Empyema: Don't Miss the Point!

    Article • Respiration, January 2013, Karger Publishers

    Prof DEMOSTHENES BOUROS

  26. Regenerative Medicine and Stem Cells: Prometheus Revisited

    Article • Respiration, January 2013, Karger Publishers

    Prof DEMOSTHENES BOUROS

  27. Stem Cell Treatment for Chronic Lung Diseases

    Article • Respiration, January 2013, Karger Publishers

    Prof DEMOSTHENES BOUROS

  28. Editorial

    Article • Current Opinion in Pulmonary Medicine, September 2012, Wolters Kluwer Health

    Prof DEMOSTHENES BOUROS

  29. Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis

    Article • International Journal of Clinical Reviews, February 2012, Remedica Medical Education and Publishing

    Prof DEMOSTHENES BOUROS

  30. Mechanisms of Pleural Involvement in Orphan Diseases

    Article • Respiration, January 2012, Karger Publishers

    Prof DEMOSTHENES BOUROS

  31. Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis

    Article • Pulmonary Medicine, January 2012, Hindawi Publishing Corporation

    Prof DEMOSTHENES BOUROS

  32. HRCT findings in the lungs of non-smokers with neurofibromatosis

    Article • European Journal of Radiology, December 2011, Elsevier

    Prof DEMOSTHENES BOUROS

  33. Chronic Obstructive Pulmonary Disease “Induced” Asymmetric Septal Hypertrophy Coincides With Latent Left Ventricular Inflammatory, Ischemic Dysfunction, Myocardial Damage and Remodeling

    Article • CHEST Journal, October 2011, Elsevier

    Prof DEMOSTHENES BOUROS

  34. Diagnostic Evaluation of Radionuclide Myocardial Imaging and Echocardiography Establishing Myopericardial Involvement in Pulmonary and Systemic Amyloidosis

    Article • CHEST Journal, October 2011, Elsevier

    Prof DEMOSTHENES BOUROS

  35. Editorial

    Article • Current Opinion in Pulmonary Medicine, September 2011, Wolters Kluwer Health

    Prof DEMOSTHENES BOUROS

  36. Pirfenidone for idiopathic pulmonary fibrosis

    Article • The Lancet, May 2011, Elsevier

    Prof DEMOSTHENES BOUROS

  37. Effect And Safety Of Mycophenolate Mofetil In Idiopathic Pulmonary Fibrosis. A Retrospective Study

    Article • May 2011, American Thoracic Society

    Prof DEMOSTHENES BOUROS

  38. The cost of COPD exacerbations: A university hospital – based study in Greece

    Article • Respiratory Medicine, March 2011, Elsevier

    Assistant Professor Paschalis Steiropoulos, Dr Evangelos C Alexopoulos, Prof DEMOSTHENES BOUROS

  39. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal

    Article • Journal of Translational Medicine, January 2011, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  40. Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis

    Article • Pulmonary Medicine, January 2011, Hindawi Publishing Corporation

    Prof DEMOSTHENES BOUROS

  41. Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis: A Review

    Article • Respiration, January 2011, Karger Publishers

    Prof DEMOSTHENES BOUROS

  42. Pleural Effusions and Thoracentesis in Patients with Hematological Malignancies

    Article • December 2010, Springer Science + Business Media

    Assistant Professor Paschalis Steiropoulos, Prof DEMOSTHENES BOUROS

  43. Iatrogenic tracheobronchial and chest injury

    Article • October 2010, Taylor & Francis

    Prof DEMOSTHENES BOUROS

  44. "Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD

    Article • BMC Pulmonary Medicine, September 2010, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  45. Continuous Positive Airway Pressure Treatment in Patients with Sleep Apnoea: Does it Really Improve Glucose Metabolism?

    Article • Current Diabetes Reviews, May 2010, Bentham Science Publishers

    Assistant Professor Paschalis Steiropoulos, Prof DEMOSTHENES BOUROS

  46. Community acquired bacterial pneumonia

    Article • Expert Opinion on Pharmacotherapy, January 2010, Informa Healthcare

    Prof DEMOSTHENES BOUROS

  47. The Microbiology of Bacterial Lung Abscess: Time for a Reappraisal?

    Article • Respiration, January 2010, Karger Publishers

    Professor Ioannis P Kioumis, Prof DEMOSTHENES BOUROS

  48. Increased Long-Term Mortality in Healthcare-Acquired Pneumonia: Another Short-Term Lease on Life?

    Article • Respiration, January 2010, Karger Publishers

    Prof DEMOSTHENES BOUROS

  49. Endotracheal Tube-associated Pneumonia

    Article • Anesthesiology, October 2009, Wolters Kluwer Health

    Prof DEMOSTHENES BOUROS

  50. Interferon gamma for idiopathic pulmonary fibrosis

    Article • The Lancet, July 2009, Elsevier

    Prof DEMOSTHENES BOUROS

  51. COPD exacerbation: Lost in translation

    Article • BMC Pulmonary Medicine, January 2009, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  52. Sleep-Disordered Breathing and Quality of Life of Railway Drivers in Greece*

    Article • CHEST Journal, July 2008, Elsevier

    Prof DEMOSTHENES BOUROS

  53. Effusions from connective tissue diseases

    Article • April 2008, Taylor & Francis

    Prof DEMOSTHENES BOUROS

  54. Current Pharmacological Treatment of Pulmonary Arterial Hypertension

    Article • Current Clinical Pharmacology, January 2008, Bentham Science Publishers

    Assistant Professor Paschalis Steiropoulos, Prof DEMOSTHENES BOUROS

  55. Pleural Effusions in Critically Ill Patients

    Article • Respiration, January 2008, Karger Publishers

    Prof DEMOSTHENES BOUROS

  56. Update on Pleural Disease: Introduction

    Article • Respiration, January 2008, Karger Publishers

    Prof DEMOSTHENES BOUROS

  57. Pleural Involvement in Systemic Autoimmune Disorders

    Article • Respiration, January 2008, Karger Publishers

    Prof DEMOSTHENES BOUROS

  58. Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis

    Article • Pulmonary Pharmacology & Therapeutics, October 2007, Elsevier

    Prof DEMOSTHENES BOUROS

  59. References to tuberculosis in Greek popular music (Rebetico)

    Article • European Journal of Internal Medicine, September 2007, Elsevier

    Prof DEMOSTHENES BOUROS

  60. Mycoplasma pneumoniae causing familial infection and acute severe respiratory failure

    Article • Respiratory Medicine Extra, January 2007, Elsevier

    Assistant Professor Paschalis Steiropoulos, Prof DEMOSTHENES BOUROS

  61. Infliximab-induced non-specific interstitial pneumonia and lupus-like eruption

    Article • European Journal of Internal Medicine, November 2006, Elsevier

    Prof DEMOSTHENES BOUROS

  62. Interferon-γ1bfor the treatment of idiopathic pulmonary fibrosis

    Article • Expert Opinion on Biological Therapy, September 2006, Informa Healthcare

    Prof DEMOSTHENES BOUROS

  63. The Clinician through the Looking Glass: Sputum Microbiology in COPD Exacerbations

    Article • Respiration, August 2006, Karger Publishers

    Prof DEMOSTHENES BOUROS

  64. Preventing nosocomial sinusitis in the ICU: reply to van Zanten et al.

    Article • Intensive Care Medicine, July 2006, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  65. Perforin Down-Regulation and Adhesion Molecules Activation in Pulmonary Sarcoidosis

    Article • CHEST Journal, June 2006, Elsevier

    Prof DEMOSTHENES BOUROS

  66. Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?

    Article • May 2006, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  67. Current medical management of pleural infection

    Article • Therapy, January 2006, Future Medicine

    Prof DEMOSTHENES BOUROS

  68. Current medical management of pleural infection

    Article • Therapy, January 2006, Future Medicine

    Prof DEMOSTHENES BOUROS

  69. Noninvasive Ventilation in Acute Pancreatitis Respiratory Failure: Deus ex Machina?

    Article • Respiration, January 2006, Karger Publishers

    Prof DEMOSTHENES BOUROS

  70. Serum biomarkers in interstitial lung diseases

    Article • July 2005, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  71. Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator

    Article • June 2005, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  72. To the Editor

    Article • CHEST Journal, May 2005, Elsevier

    Prof DEMOSTHENES BOUROS

  73. IL-18: A Role in Nonspecific Interstitial Pneumonitis Pathogenesis and Discrimination?

    Article • Respiration, January 2005, Karger Publishers

    Prof DEMOSTHENES BOUROS

  74. Pleural Fluid pH in Parapneumonic Pleural Effusions: Drawing the Line

    Article • Respiration, January 2005, Karger Publishers

    Prof DEMOSTHENES BOUROS

  75. Application of microarray technology in pulmonary diseases

    Article • December 2004, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  76. Use of interrupter technique in assessment of bronchial responsiveness in normal subjects

    Article • BMC Pulmonary Medicine, November 2004, Springer Science + Business Media

    Prof DEMOSTHENES BOUROS

  77. Top Ten List in Idiopathic Pulmonary Fibrosis

    Article • CHEST Journal, May 2004, Elsevier

    Prof DEMOSTHENES BOUROS

  78. Pleural Effusions in Hematologic Malignancies

    Article • CHEST Journal, April 2004, Elsevier

    Prof DEMOSTHENES BOUROS

  79. Pleural Disease

    Article • February 2004, Taylor & Francis

    Prof DEMOSTHENES BOUROS

  80. Bronchoscopic Lung Volume Reduction: A Window for the Future?

    Article • Respiration, January 2004, Karger Publishers

    Prof DEMOSTHENES BOUROS

  81. Interferons and Their Application in Lung Diseases

    Article • CHEST Journal, December 2003, Elsevier

    Prof DEMOSTHENES BOUROS

  82. Fat Embolism Syndrome

    Article • CHEST Journal, April 2003, Elsevier

    Prof DEMOSTHENES BOUROS

  83. Interferons and Their Application in the Diseases of the Lung

    Article • CHEST Journal, January 2003, Elsevier

    Prof DEMOSTHENES BOUROS

  84. Pleural Fluid Polymorphonuclear Elastase: Cui bono?

    Article • Respiration, January 2003, Karger Publishers

    Prof DEMOSTHENES BOUROS

  85. The Trans-Exudative Pleural Effusion

    Article • CHEST Journal, November 2002, Elsevier

    Prof DEMOSTHENES BOUROS

  86. Pneumonology or Pneumology?

    Article • CHEST Journal, May 2002, Elsevier

    Prof DEMOSTHENES BOUROS

  87. Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes

    Article • CHEST Journal, April 2002, Elsevier

    Prof DEMOSTHENES BOUROS

  88. Diagnostic Value of Interleukin-1α, Interleukin-6, and Tumor Necrosis Factor in Pleural Effusions

    Article • CHEST Journal, March 2002, Elsevier

    Prof DEMOSTHENES BOUROS

  89. The Relationships Among Hydrogen Peroxide in Expired Breath Condensate, Airway Inflammation, and Asthma Severity

    Article • CHEST Journal, February 2002, Elsevier

    Prof DEMOSTHENES BOUROS

  90. Exhaled H2O2 in Steady-State Bronchiectasis

    Article • CHEST Journal, January 2002, Elsevier

    Prof DEMOSTHENES BOUROS

  91. Short-term Effects of Wood Smoke Exposure on the Respiratory System Among Charcoal Production Workers

    Article • CHEST Journal, April 2001, Elsevier

    Prof DEMOSTHENES BOUROS

  92. Endoluminal Metastases of the Tracheobronchial Tree

    Article • CHEST Journal, March 2001, Elsevier

    Prof DEMOSTHENES BOUROS

  93. Pleurodesis Everything Flows

    Article • CHEST Journal, September 2000, Elsevier

    Prof DEMOSTHENES BOUROS

  94. Microsatellite DNA Instability in COPD

    Article • CHEST Journal, July 1999, Elsevier

    Prof DEMOSTHENES BOUROS

  95. Pneumothorax as a First Manifestation of Sarcoidosis

    Article • CHEST Journal, July 1997, Elsevier

    Prof DEMOSTHENES BOUROS

  96. Pulmonary Involvement in a Case of Plasmodium vivax Malaria

    Article • CHEST Journal, March 1997, Elsevier

    Prof DEMOSTHENES BOUROS

  97. Natural history of patients with pulmonary metastases from uterine cancer

    Article • Cancer, August 1996, Wiley

    Prof DEMOSTHENES BOUROS

  98. Patterns of Pulmonary Metastasis from Uterine Cancer

    Article • Oncology, January 1996, Karger Publishers

    Prof DEMOSTHENES BOUROS

  99. Respiratory Muscle Strength in Hypothyroidism

    Article • CHEST Journal, July 1992, Elsevier

    Prof DEMOSTHENES BOUROS

  100. Palpation vs Pen Method for the Measurement of Skin Tuberculin Reaction (Mantoux Test)

    Article • CHEST Journal, February 1991, Elsevier

    Prof DEMOSTHENES BOUROS

  101. Primary Biliary Cirrhosis and Sarcoidosis

    Article • CHEST Journal, December 1989, Elsevier

    Prof DEMOSTHENES BOUROS

  102. Spontaneous Pneumothorax

    Article • CHEST Journal, December 1986, Elsevier

    Prof DEMOSTHENES BOUROS

  103. Why do Only Some Smokers Develop COPD?

    Article • Wiley

    Prof DEMOSTHENES BOUROS